Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 11 2021
Historique:
received: 04 11 2020
accepted: 01 09 2021
pubmed: 10 9 2021
medline: 15 12 2021
entrez: 9 9 2021
Statut: ppublish

Résumé

Formation of NO by endothelial NOS (eNOS) is a central process in the homeostatic regulation of vascular functions including blood pressure regulation, and fluid shear stress exerted by the flowing blood is a main stimulus of eNOS activity. Previous work has identified several mechanosensing and -transducing processes in endothelial cells, which mediate this process and induce the stimulation of eNOS activity through phosphorylation of the enzyme via various kinases including AKT. How the initial mechanosensing and signaling processes are linked to eNOS phosphorylation is unclear. In human endothelial cells, we demonstrated that protein kinase N2 (PKN2), which is activated by flow through the mechanosensitive cation channel Piezo1 and Gq/G11-mediated signaling, as well as by Ca2+ and phosphoinositide-dependent protein kinase 1 (PDK1), plays a pivotal role in this process. Active PKN2 promoted the phosphorylation of human eNOS at serine 1177 and at a newly identified site, serine 1179. These phosphorylation events additively led to increased eNOS activity. PKN2-mediated eNOS phosphorylation at serine 1177 involved the phosphorylation of AKT synergistically with mTORC2-mediated AKT phosphorylation, whereas active PKN2 directly phosphorylated human eNOS at serine 1179. Mice with induced endothelium-specific deficiency of PKN2 showed strongly reduced flow-induced vasodilation and developed arterial hypertension accompanied by reduced eNOS activation. These results uncover a central mechanism that couples upstream mechanosignaling processes in endothelial cells to the regulation of eNOS-mediated NO formation, vascular tone, and blood pressure.

Identifiants

pubmed: 34499618
pii: e145734
doi: 10.1172/JCI145734
pmc: PMC8553558
doi:
pii:

Substances chimiques

NOS3 protein, human EC 1.14.13.39
Nitric Oxide Synthase Type III EC 1.14.13.39
Nos3 protein, mouse EC 1.14.13.39
protein kinase N EC 2.7.1.-
Mechanistic Target of Rapamycin Complex 2 EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Protein Kinase C EC 2.7.11.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Références

Cell Death Dis. 2016 Oct 20;7(10):e2431
pubmed: 27763641
J Clin Invest. 2000 Aug;106(4):493-9
pubmed: 10953024
Br J Pharmacol. 2019 Jan;176(2):189-196
pubmed: 30341769
J Biol Chem. 2002 Nov 1;277(44):42344-51
pubmed: 12171920
J Biol Chem. 2000 Mar 3;275(9):6123-8
pubmed: 10692402
Am J Physiol. 1998 Nov;275(5):H1898-904
pubmed: 9815099
Cell Signal. 2011 Oct;23(10):1515-27
pubmed: 21620960
EMBO J. 1996 Dec 2;15(23):6541-51
pubmed: 8978681
Stroke. 2013 Nov;44(11):3183-8
pubmed: 23988642
J Pharmacol Sci. 2015 Oct;129(2):83-94
pubmed: 26499181
PLoS One. 2011;6(7):e21732
pubmed: 21754995
J Cell Biol. 2002 Jan 7;156(1):137-48
pubmed: 11777936
J Biol Chem. 2002 May 24;277(21):19087-94
pubmed: 11839759
Physiol Rev. 2009 Apr;89(2):481-534
pubmed: 19342613
Eur J Cell Biol. 2013 Oct-Nov;92(10-11):303-15
pubmed: 24183240
Nature. 1999 Jun 10;399(6736):601-5
pubmed: 10376603
J Biol Chem. 2005 Dec 9;280(49):40406-16
pubmed: 16221682
EMBO J. 2001 Sep 3;20(17):4639-47
pubmed: 11532928
J Biol Chem. 2009 Oct 30;284(44):30318-27
pubmed: 19723632
Cell Signal. 2016 Mar;28(3):117-124
pubmed: 26706435
Br J Pharmacol. 2006 Mar;147(5):506-15
pubmed: 16415911
J Mol Cell Cardiol. 2019 Mar;128:212-226
pubmed: 30742812
Science. 1996 Feb 2;271(5249):648-50
pubmed: 8571127
Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1281-7
pubmed: 16601232
Pflugers Arch. 2010 May;459(6):793-806
pubmed: 20012875
J Clin Invest. 2006 Feb;116(2):334-43
pubmed: 16453020
Curr Top Microbiol Immunol. 2010;346:31-56
pubmed: 20517722
J Biol Chem. 2017 Aug 25;292(34):14188-14204
pubmed: 28634229
Pflugers Arch. 2016 Jul;468(7):1125-1137
pubmed: 27184745
Mol Cell Proteomics. 2019 Aug;18(8):1700-1702
pubmed: 31097673
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Biophys J. 2013 May 21;104(10):2295-306
pubmed: 23708369
Cell Rep. 2016 Jan 26;14(3):440-448
pubmed: 26774483
J Biol Chem. 2004 Jul 9;279(28):29654-69
pubmed: 15123640
Free Radic Biol Med. 2003 Oct 1;35(7):729-41
pubmed: 14583337
Sci Rep. 2020 Mar 3;10(1):3902
pubmed: 32127582
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
J Exp Med. 2009 Feb 16;206(2):411-20
pubmed: 19171764
J Clin Invest. 2019 Jun 17;129(7):2775-2791
pubmed: 31205027
Nat Commun. 2018 Nov 2;9(1):4600
pubmed: 30389913
Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1819-28
pubmed: 12384459
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):870-879
pubmed: 29449333
Genesis. 2000 Nov-Dec;28(3-4):106-10
pubmed: 11105051
J Biol Chem. 2003 Apr 25;278(17):14841-9
pubmed: 12591925
Br J Pharmacol. 2012 May;166(1):151-67
pubmed: 22014233
Biochem Biophys Res Commun. 2013 Feb 8;431(2):284-90
pubmed: 23291238
Blood. 2009 May 28;113(22):5680-8
pubmed: 19144989
Mol Cell Biol. 2003 Nov;23(22):8019-29
pubmed: 14585963
Genes Cells. 2017 Feb;22(2):220-236
pubmed: 28102564
J Clin Invest. 2015 Aug 3;125(8):3077-86
pubmed: 26168216
Am J Physiol. 1991 Aug;261(2 Pt 2):H598-603
pubmed: 1652215
Sci Signal. 2009 Aug 04;2(82):ra41
pubmed: 19654415
J Biol Chem. 1997 Nov 21;272(47):29769-77
pubmed: 9368047
J Clin Invest. 2007 Jul;117(7):1961-7
pubmed: 17557122
J Biol Chem. 2004 Nov 12;279(46):47438-45
pubmed: 15339913
Curr Biol. 1997 Apr 1;7(4):261-9
pubmed: 9094314
Cell. 2017 Apr 20;169(3):381-405
pubmed: 28431241
J Biol Chem. 2002 Feb 1;277(5):3388-96
pubmed: 11729190
J Biol Chem. 2002 Jun 14;277(24):21639-42
pubmed: 11956222
J Biol Chem. 2000 Jul 7;275(27):20806-13
pubmed: 10764742
Biochemistry. 2013 Nov 12;52(45):7999-8011
pubmed: 24128008
EMBO J. 2000 Mar 1;19(5):979-88
pubmed: 10698939
Nature. 2005 Sep 15;437(7057):426-31
pubmed: 16163360
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20210-20217
pubmed: 31527268
Nature. 1999 Jun 10;399(6736):597-601
pubmed: 10376602
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470
J Biol Chem. 2000 Nov 3;275(44):34451-8
pubmed: 10926925
J Clin Invest. 2016 Dec 1;126(12):4527-4536
pubmed: 27797339
Front Physiol. 2013 Dec 13;4:347
pubmed: 24379783
Mol Cell Biol. 1997 Apr;17(4):2247-56
pubmed: 9121475
Science. 1996 Feb 2;271(5249):645-8
pubmed: 8571126

Auteurs

Young-June Jin (YJ)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

Ramesh Chennupati (R)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

Rui Li (R)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

Guozheng Liang (G)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

ShengPeng Wang (S)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Cardiovascular Research Center, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Yanta District, Xi'an, China.

András Iring (A)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Laboratory of Molecular Medicine, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.

Johannes Graumann (J)

Scientific Service Group Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.

Nina Wettschureck (N)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Centre for Molecular Medicine, Medical Faculty, JW Goethe University Frankfurt, Frankfurt, Germany.
Cardiopulmonary Institute (CPI), Frankfurt, Germany.
German Center for Cardiovascular Research (DZHK), Rhine-Main Site, Frankfurt and Bad Nauheim, Germany.

Stefan Offermanns (S)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Centre for Molecular Medicine, Medical Faculty, JW Goethe University Frankfurt, Frankfurt, Germany.
Cardiopulmonary Institute (CPI), Frankfurt, Germany.
German Center for Cardiovascular Research (DZHK), Rhine-Main Site, Frankfurt and Bad Nauheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH